Weight Regain Concerns After Stopping GLP-1 Medications

Many individuals who have successfully shed pounds using Ozempic and similar GLP-1 agonist drugs are finding it challenging to quit these injectables. According to reports, the return of intense hunger is leading to weight regain, suggesting that some may develop a long-term reliance on these medications.

Tanya Hall, a Wegovy user, shared her experience, stating, “For the first 38 years of my life, I was overweight — now I’m six stone [83 pounds] lighter. There’s a part of me that feels there’s an addiction to keep using it because it gives me a sense of control.”

Research has shown that many patients regain most of their weight after discontinuing these treatments. Celebrities like Oprah have acknowledged this challenge, with Oprah revealing her intention to remain on the medication indefinitely, likening her need for it to her reliance on high blood pressure medication. “I’ve realized I need it,” she remarked.

For those who manage to stop taking these drugs, studies indicate they tend to regain about two-thirds of their lost weight. Dr. Hussain Al-Zubaidi noted that he has observed patients regaining 60 to 80 percent of their weight loss.

However, Dr. Al-Zubaidi also emphasized that it’s not necessarily hopeless. He suggested that patients create an “exit strategy” that includes healthier lifestyle changes developed while using the injectables, which can help maintain weight loss after they stop the medication.

Ellen Ogley illustrated this point, mentioning that she lost 48.5 pounds on Eli Lilly’s GLP-1 drug, Mounjaro, while adopting better eating habits and exercising regularly. Even after some time off the drugs, she has managed to maintain her weight loss. “I want people to know that life after Mounjaro can be sustainable,” she said.